159d526d234af18e…
StudyID:
NCT00041678683 bytesFirst seen Jun 12, 20261 collectionFields
| Name | Value |
|---|---|
| briefSummary | The purpose of this study is to learn if aripiprazole is safe and effective in the treatment of psychosis associated with dementia of the Alzheimer's type. |
| completionDate | 2003-03 |
| conditions | ["Alzheimer Disease"] |
| enrollmentCount | null |
| enrollmentType | null |
| nctId | NCT00041678 |
| phase | PHASE3 |
| sponsorId | otsuka-pharmaceutical-development-commercialization-inc |
| startDate | 2000-01 |
| status | COMPLETED |
| studyType | INTERVENTIONAL |
| title | Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type |
| url | https://clinicaltrials.gov/study/NCT00041678 |
Canonical JSON
{
"id": "NCT00041678",
"type": "Study",
"data": {
"briefSummary": "The purpose of this study is to learn if aripiprazole is safe and effective in the treatment of psychosis associated with dementia of the Alzheimer's type.",
"completionDate": "2003-03",
"conditions": [
"Alzheimer Disease"
],
"enrollmentCount": null,
"enrollmentType": null,
"nctId": "NCT00041678",
"phase": "PHASE3",
"sponsorId": "otsuka-pharmaceutical-development-commercialization-inc",
"startDate": "2000-01",
"status": "COMPLETED",
"studyType": "INTERVENTIONAL",
"title": "Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type",
"url": "https://clinicaltrials.gov/study/NCT00041678"
}
}Appears in 1 collection
nih/clinical-trials1 version · Jun 12, 2026
Full hash:159d526d234af18e3a34714230e7d1937301d5d9320551c4e879e4b16276ad90